The latest price target for Cardinal Health (NYSE:CAH) was reported by Morgan Stanley on November 4, 2024. The analyst firm set a price target for $127.00 expecting CAH to rise to within 12 months (a possible 4.24% upside). 28 analyst firms have reported ratings in the last year.

The latest analyst rating for Cardinal Health (NYSE:CAH) was provided by Morgan Stanley, and Cardinal Health maintained their overweight rating.

The last upgrade for Cardinal Health Inc happened on February 9, 2024 when Argus Research raised their price target to N/A. Argus Research previously had a hold for Cardinal Health Inc.

The last downgrade for Cardinal Health Inc happened on July 10, 2023 when Evercore ISI Group changed their price target from N/A to $100 for Cardinal Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardinal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardinal Health was filed on November 4, 2024 so you should expect the next rating to be made available sometime around November 4, 2025.

While ratings are subjective and will change, the latest Cardinal Health (CAH) rating was a maintained with a price target of $119.00 to $127.00. The current price Cardinal Health (CAH) is trading at is $121.84, which is within the analyst’s predicted range.